Am J Cardiol

1. NARINS CR
   Rotational Atherectomy in Women.
   Am J Cardiol. 2024;220:122-124.
   

   >> Share

   
   
2. PRASADA S, Stouffer GA
   Atherectomy and Peri-Procedural Myocardial Infarction-When Does It Matter?
   Am J Cardiol. 2024 May 17:S0002-9149(24)00362.
   

   >> Share

   
   
3. KEMBERI M, Urgesi E, ngYong Ng J, Patel K, et al
   Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction Undergoing Surgical Revascularization.
   Am J Cardiol. 2024 May 20:S0002-9149(24)00383.
   

   >> Share

   
   
4. MUTLU D, Brilakis ES
   The Role of Retrograde Crossing in Short Coronary Chronic Total Occlusions.
   Am J Cardiol. 2024;220:120-121.
   

   >> Share

   
   
5. DOSHI A, Gandhi H, Patel KN, Majmundar M, et al
   Aspirin for Primary Prevention in Patients With Elevated Coronary Artery Calcium Score: A Systematic Review of Current Evidences.
   Am J Cardiol. 2024;220:9-15.
   

   >> Share

   
   
6. TORNYOS D, Lukacs R, Janosi A, Komocsi A, et al
   Prognosis Impact and Prediction of Trans-Radial Access Failure in Patients With STEMI, A Nationwide Observational Study.
   Am J Cardiol. 2024;220:23-32.
   

   >> Share

   
   
7. MORONI A, Ayoub M, Gorgulu S, Werner GS, et al
   Impact of Bifurcation Involvement and Location in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the EuroCTO Registry.
   Am J Cardiol. 2024 May 22:S0002-9149(24)00399.
   

   >> Share

   
   
8. ALFONSO F, Marschall A
   Left Main Coronary Artery Revascularization: Looking for Vascular Disease Beyond the Coronary Tree.
   Am J Cardiol. 2024 May 19:S0002-9149(24)00365.
   

   >> Share

   
   
9. ANG DTY, Abraham G, Sim KYT, Sidik NP, et al
   Comparing Pressure-Bounded Versus Thermodilution-Derived Coronary Flow Reserve in Unobstructed Coronary Arteries.
   Am J Cardiol. 2024 May 19:S0002-9149(24)00366.
   

   >> Share

   
   
10. D'ENTREMONT MA, Tiong D, Sadeghirad B, McGrath BP, et al
    Assessment Of Coronary Stenoses For Percutaneous Coronary Intervention: A Systematic Review And Network Meta-Analysis Of Randomized Trials.
    Am J Cardiol. 2024 May 18:S0002-9149(24)00373.
    

    >> Share

    
    
11. PANUCCIO G, Werner GS, De Rosa S, Torella D, et al
    Full-moon coronary calcification as detected with computed tomography angiography in chronic total occlusion percutaneous coronary intervention.
    Am J Cardiol. 2024 May 16:S0002-9149(24)00364.
    

    >> Share

    
    

    
    Angiology

12. ANG SP, Chia JE, Misra K, Krittanawong C, et al
    Autoimmune Rheumatic Diseases and Outcomes Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Angiology. 2024 May 21:33197241255167. doi: 10.1177/00033197241255167.
    

    >> Share

    
    
13. LIN Z, He J, Song C, Zhang R, et al
    The Neutrophil to Lymphocyte Ratio Modifies Lipoprotein (a)-Related Poor Prognosis in Patients After Percutaneous Coronary Intervention.
    Angiology. 2024 May 19:33197241255414. doi: 10.1177/00033197241255414.
    

    >> Share

    
    

    
    Ann Intern Med

14. WEITZ HH, Merli GJ, Carson JL
    Web Exclusive. Annals Consult Guys - Acute Coronary Syndrome and Anemia: When to Transfuse?
    Ann Intern Med. 2024;177:eW240002.
    

    >> Share

    
    
15. BATES ER
    In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo.
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0026.
    

    >> Share

    
    

    
    Can J Cardiol

16. TSUNETA S, Suno K, Fujieda Y, Watanabe M, et al
    Accumulation of Technetium-99m Tetrofosmin on Myocardial Perfusion Scintigraphy in a Patient With Immunoglobulin G4-Related Coronary Periarteritis.
    Can J Cardiol. 2024;40:450-451.
    

    >> Share

    
    

    
    Circ Cardiovasc Imaging

17. COUNTOURIS ME, Catov JM, Zhu J, de Jong N, et al
    Association of Hypertensive Disorders of Pregnancy With Coronary Microvascular Dysfunction 8 to 10 Years After Delivery.
    Circ Cardiovasc Imaging. 2024;17:e016561.
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

18. NICOLAS J, Pitaro N, Sartori S, Spirito A, et al
    Incidence and Impact of Contrast-Associated Acute Kidney Injury in Patients With High-Bleeding Risk Undergoing Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2024;17:e013835.
    

    >> Share

    
    
19. JO HH, Kang DY, Lee JM, Lim SM, et al
    Evaluation of Instantaneous Wave-Free Ratio and Fractional Flow Reserve in Severe Aortic Valve Stenosis.
    Circ Cardiovasc Interv. 2024 Apr 17:e013237.
    

    >> Share

    
    
20. AURIGEMMA C, Ding D, Tu S, Li C, et al
    Three-year Clinical Impact of Murray Law-Based Quantitative Flow Ratio and OCT- or FFR-Guidance in Angiographically Intermediate Coronary Lesions.
    Circ Cardiovasc Interv. 2024 Apr 25:e013191.
    

    >> Share

    
    
21. NAKAMURA K, Henry TD, Traverse JH, Latter DA, et al
    Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.
    Circ Cardiovasc Interv. 2024;17:e014054.
    

    >> Share

    
    
22. ODANOVIC N, Parikh RV, Shah SM
    Finding the Optimal Strategy for Nonculprit Revascularization in Acute Myocardial Infarction: The Role of Angiography-Derived Physiology.
    Circ Cardiovasc Interv. 2024;17:e014129.
    

    >> Share

    
    
23. KORJIAN S, McCarthy KJ, Larnard EA, Cutlip DE, et al
    Drug-Coated Balloons in the Management of Coronary Artery Disease.
    Circ Cardiovasc Interv. 2024;17:e013302.
    

    >> Share

    
    
24. KWON W, Choi KH, Lee SH, Hong D, et al
    Clinical Value of Single-Projection Angiography-Derived FFR in Noninfarct-Related Artery.
    Circ Cardiovasc Interv. 2024;17:e013844.
    

    >> Share

    
    
25. PUYMIRAT E, Cayla G, Simon T, Steg PG, et al
    Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction.
    Circ Cardiovasc Interv. 2024 May 24:e013913.
    

    >> Share

    
    

    
    Circ Cardiovasc Qual Outcomes

26. THOMPSON MP, Hou H, Likosky DS, Pagani FD, et al
    Home Health Care Use and Outcomes After Coronary Artery Bypass Grafting Among Medicare Beneficiaries.
    Circ Cardiovasc Qual Outcomes. 2024 May 21:e010459.
    

    >> Share

    
    
27. CURRY LA, Carter CR, Cherlin E, Toraman Turk S, et al
    Qualitative and Mixed Methods Research in Cardiovascular Care: Opportunities in the Coming Decades.
    Circ Cardiovasc Qual Outcomes. 2024;17:e010586.
    

    >> Share

    
    
28. SIMADER FA, Al-Lamee RK
    To Test or Not to Test? The Utility of Noninvasive Cardiac Testing for Chest Pain Without Myocardial Infarction.
    Circ Cardiovasc Qual Outcomes. 2024 May 23:e011017.
    

    >> Share

    
    

    
    Circ Genom Precis Med

29. ARMOUNDAS AA, Ahmad FS, Bennett DA, Chung MK, et al
    Data Interoperability for Ambulatory Monitoring of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circ Genom Precis Med. 2024 May 23:e000095. doi: 10.1161/HCG.0000000000000095.
    

    >> Share

    
    

    
    Circ Heart Fail

30. PATEL SM, Berg DD, Bohula EA, Baird-Zars VM, et al
    Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network Registry.
    Circ Heart Fail. 2024;17:e011736.
    

    >> Share

    
    

    
    Circ J

31. OKADA K
    Role of Sex Difference in Modifiable Risk Factors After Acute Myocardial Infarction.
    Circ J. 2024 May 22. doi: 10.1253/circj.CJ-24-0289.
    

    >> Share

    
    

    
    Circ Res

32. AFOLABI JM, Kirabo A
    HIV and Cardiovascular Disease.
    Circ Res. 2024;134:1512-1514.
    

    >> Share

    
    
33. NIWAHA AJ, Byrd JB
    Cardiovascular Dynamics in HIV: The Influence of Adrenal Function and Nutritional Status.
    Circ Res. 2024;134:1566-1580.
    

    >> Share

    
    
34. HUDSON JA, Ferrand RA, Gitau SN, Mureithi MW, et al
    HIV-Associated Cardiovascular Disease Pathogenesis: An Emerging Understanding Through Imaging and Immunology.
    Circ Res. 2024;134:1546-1565.
    

    >> Share

    
    
35. HINTON AO JR, N'jai AU, Vue Z, Wanjalla C, et al
    Connection Between HIV and Mitochondria in Cardiovascular Disease and Implications for Treatments.
    Circ Res. 2024;134:1581-1606.
    

    >> Share

    
    
36. OBARE LM, Temu T, Mallal SA, Wanjalla CN, et al
    Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease.
    Circ Res. 2024;134:1515-1545.
    

    >> Share

    
    

    
    Circulation

37. 
    Correction to: 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1218.
    

    >> Share

    
    
38. SATTAR N, Neeland IJ, McGuire DK
    Obesity and Cardiovascular Disease: A New Dawn.
    Circulation. 2024;149:1621-1623.
    

    >> Share

    
    
39. ZHU Q, Scherer PE
    Ceramides and Atherosclerotic Cardiovascular Disease: A Current Perspective.
    Circulation. 2024;149:1624-1626.
    

    >> Share

    
    

    
    Clin Cardiol

40. KHORSANDI M, Blumenthal RS, Blaha MJ, Kohli P, et al
    The ABCs of the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease.
    Clin Cardiol. 2024;47:e24284.
    

    >> Share

    
    

    
    Dtsch Med Wochenschr

41. ROMANN SW, Frey N, Lehmann L
    [The Cardio-Oncology Guideline - A Comprehensive Approach to Managing Cardiovascular Risks in Cancer Patients].
    Dtsch Med Wochenschr. 2024;149:719-723.
    

    >> Share

    
    

    
    Heart

42. SANDOVAL Y, Jaffe AS
    Caveats of high-sensitivity cardiac troponin rapid risk stratification protocols: one size does not fit all.
    Heart. 2024;110:821-822.
    

    >> Share

    
    
43. MILLARD MJ, Ashburn NP, Snavely AC, Hashemian T, et al
    European Society of Cardiology 0/1-hour algorithm (high-sensitivity cardiac troponin T) performance across distinct age groups.
    Heart. 2024;110:838-845.
    

    >> Share

    
    

    
    Int J Cardiol

44. YAO L, Hao K, Liu T, Jiang J, et al
    The miR-26b/CTGF axis: A promising therapeutic mechanism for managing myocardial fibrosis post myocardial infarction.
    Int J Cardiol. 2024;409:132185.
    

    >> Share

    
    
45. UKITA K, Egami Y, Yano M, Nishino M, et al
    Reply to "Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?".
    Int J Cardiol. 2024;409:132187.
    

    >> Share

    
    
46. CHEN G, Westra J, Yang X, Zhang Y, et al
    A simple Angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction.
    Int J Cardiol. 2024 May 21:132199. doi: 10.1016/j.ijcard.2024.132199.
    

    >> Share

    
    

    
    J Am Coll Cardiol

47. LECHNER I, Reindl M, Stiermaier T, Tiller C, et al
    Clinical Outcomes Associated With Various Microvascular Injury Patterns Identified by CMR After STEMI.
    J Am Coll Cardiol. 2024;83:2052-2062.
    

    >> Share

    
    
48. DHARMAKUMAR R, Kumar A
    Hemorrhagic Myocardial Infarction: Light After 50 Years in the Tunnel.
    J Am Coll Cardiol. 2024;83:2063-2065.
    

    >> Share

    
    
49. GUNER A, Akturk IF, Cizgici AY, Uzun F, et al
    Intravascular Imaging for Complex Coronary Intervention.
    J Am Coll Cardiol. 2024;83:e207.
    

    >> Share

    
    
50. KANG DY, Ahn JM, Park SJ, Park DW, et al
    Reply: Intravascular Imaging for Complex Coronary Intervention.
    J Am Coll Cardiol. 2024;83:e209.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

51. STOKAR J, Szalat A
    Response to Letter to the Editor from Kawaguchi: 'Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study.
    J Clin Endocrinol Metab. 2024 May 20:dgae348. doi: 10.1210.
    

    >> Share

    
    

    
    J Mol Cell Cardiol

52. KISKIN FN, Yang Y, Yang H, Zhang JZ, et al
    Cracking the code of the cardiovascular enigma: hPSC-derived endothelial cells unveil the secrets of endothelial dysfunction.
    J Mol Cell Cardiol. 2024;192:65-78.
    

    >> Share

    
    

    
    Lancet

53. COUTTS SB, Ankolekar S, Appireddy R, Arenillas JF, et al
    Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
    Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921.
    

    >> Share

    
    

    
    Mayo Clin Proc

54. HAWKINS-VAN DER CINGEL G, Walsh SB, Eckardt KU, Knauf F, et al
    Oxalate Metabolism: From Kidney Stones to Cardiovascular Disease.
    Mayo Clin Proc. 2024 May 16:S0025-6196(24)00090.
    

    >> Share

    
    

    
    Mol Cell Biochem

55. SHI K, Jiao Y, Yang L, Yuan G, et al
    New insights into the roles of olfactory receptors in cardiovascular disease.
    Mol Cell Biochem. 2024 May 18. doi: 10.1007/s11010-024-05024.
    

    >> Share

    
    

    
    PLoS One

56. XU L, Wang Y, Ji H, Du W, et al
    Frailty and risk of systemic atherosclerosis: A bidirectional Mendelian randomization study.
    PLoS One. 2024;19:e0304300.
    

    >> Share

    
    
57. XU P, Wei Y, Wu H, Zhang L, et al
    Genetic associations between Rapid Eye Movement (REM) sleep behavior disorder and cardiovascular diseases.
    PLoS One. 2024;19:e0301112.
    

    >> Share

    
    
58. PAN-LIZCANO R, Nunez L, Pinon P, Aldama G, et al
    lncRNA CDKN2B-AS1 is downregulated in patients with ventricular fibrillation in acute myocardial infarction.
    PLoS One. 2024;19:e0304041.
    

    >> Share

    
    

    
    Thromb Haemost

59. UEKI Y, Haner JD, Losdat S, Gargiulo G, et al
    Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
    Thromb Haemost. 2024;124:517-527.
    

    >> Share

    
    
60. CATTANEO M, Squizzato A, Birocchi S, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2024;124:595-597.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share